EPCAM and neoplasm: Moreover, IF staining showed that the tumor stem cell markers CD133 and EpCAM were both highly expressed in recurrent samples compared with the expression in initial tumors (CD133+: 19 vs. 5%, p = 0.002; EpCAM+:15 vs. 6%, p = 0.005) (Figure 3B).